₹ 170.7
Key Takeaways
Risk factor
Very poor trading liquidity
Data is available to registered users only
Data is available to registered users only
Profitability factor
Low dividends
Data is available to registered users only
Data is available to registered users only
About
Sanjivani Paranteral Ltd. is a pharmaceutical company that manufactures and supplies a variety of medical products. Its offerings include medications such as antibiotics, anti-emetics, anti-diabetics, and anti-fungals. The firm was established on October 5, 1994, by Anami H. Khemka, Ashwin A. Khemka, and Somesh Khemka, and its central operations are based in Mumbai, India.
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, of fair value on E
Data is available to registered users only